Identification of in Vivo Phosphorylation Sites on Human Deoxycytidine Kinase
Authors:
- Didier VertommenDVDidier Vertommen
- Luc BertrandLBLuc Bertrand
- Sandrine NtamashimikiroSNSandrine Ntamashimikiro
- Mark H. RiderMRMark H. Rider
- Eric Van Den NesteENEric Van Den Neste
- Françoise BontempsFBFrançoise Bontemps
Open Access
- 1 February 2006
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (8) , 4887-4893
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Antiviral drugs in current clinical useJournal of Clinical Virology, 2004
- Mechanism of action of purine analogues in chronic lymphocytic leukaemiaBritish Journal of Haematology, 2003
- Nucleoside analogues and nucleobases in cancer treatmentThe Lancet Oncology, 2002
- Nucleoside analogues: mechanisms of drug resistance and reversal strategiesLeukemia, 2001
- High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemiaBlood, 2000
- On the Phosphorylation of 2-chlorodeoxy-adenosine (CdA) and Its Correlation with Clinical Response in Leukemia TreatmentLeukemia & Lymphoma, 1996
- In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2′-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) geneAnnals of Hematology, 1995
- Mammalian deoxyribonucleoside kinasesPharmacology & Therapeutics, 1995
- Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosineBlood, 1993
- Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.Proceedings of the National Academy of Sciences, 1980